Publications by authors named "Mami Fukuma"
Article Synopsis
- The study examined the effects of ultra-low dosage estrogen replacement therapy on final height and bone mineral density (BMD) in 17 Turner syndrome patients starting treatment between ages 9.8-13.7, alongside growth hormone therapy from age 7.4.
- Group E exhibited a final height of 152.4 cm, significantly Taller than group L (148.5 cm), which received a different estrogen dosage starting later.
- Despite achieving good final height outcomes with the ultra-low estrogen dose, group E's bone mineral density was not ideal compared to group S, who experienced natural breast development and menarche.
